Maxigen Biotech Inc operates in the Toilet preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Maxigen Biotech Inc with three other
cosmetics and toiletry producers in Asia:
sales of 1.89 billion Pakistan Rupees [US$12.13 million]
Asian Phytoceuticals PCL
(369.83 million Thai Bahts [US$12.18 million]
of which 100%
was Dietary Supplement), and
Eng Kah Corporation Bhd
based in Malaysia
(57.82 million Malaysian Ringgits [US$13.95 million]
Maxigen Biotech Inc reported sales of 427.68 million Taiwanese Dollars (US$14.06 million)
December of 2018.
a very small
increase of 0.0%
versus 2017, when the company's sales were 427.56 million Taiwanese Dollars.
Sales at Maxigen Biotech Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 84%).
Sales of Medicine saw an increase
that was more than double the company's growth rate: sales were up
19.7% in 2018, from
221.01 million Taiwanese Dollars to 264.51 million Taiwanese Dollars.
Not all segments of Maxigen Biotech Inc experienced an increase in sales in 2018:
sales of Consumer Products fell 21.0% to 163.18 million Taiwanese Dollars.